In our trial, neither age nor preexisting diabetes mellitus, cancer disease, infectious disease, abscess in the past, infection with other catheter material in the past, prolonged corticosteroid therapy or short term corticosteroid therapy perioperatively were indicators for an increased risk.
Duration of daily filgrastim prophylaxis during the patient-cycle was characterized based on temporal patterns of administration; end of prophylaxis was defined as a gap ≥3 days in its use, outpatient administration of IV antimicrobial therapy (an indicator for possible CINC), or hospitalization for CINC.
Increased oxygenation levels were also induced in tumors partially responsive to chemotherapy and could be valuable indicators for therapy monitoring.
There is no clinical reason to rule out supply of a non-prescription triptan in either situation, although referral to a doctor is appropriate because prolonged or frequent migraine attacks may be indicators for prophylactic therapy and/or further investigation.
We studied 50 consecutive symptomatic NICSMR patients for a median follow-up of 2.5 years after mitral surgery and concluded that the pre-operative 2-dimensional speckle tracking echocardiography-derived left ventricular torsional profile and QRS width/cardiac resynchronization therapy are potentially important prognostic indicators for post-surgery survival and reverse remodeling.
Some of the drugs considered inappropriate in many other lists are even presented as rational therapy according to the Swedish indicators; for example, zopiclone, spironolactone and nitrofurantoin.
Our study thus suggests that expression status of phospho-mTOR and phospho-S6RP may be applied as potential efficacy predictors for everolimus therapy in mRCC patients and indicators for selection of everolimus-responsive mRCC patients.
Therefore, identifying gene and protein markers will facilitate the development of novel diagnostic and prognostic indicators for improved therapies and individualized treatments in patients with breast cancer.
In our study, being under lipid-lowering therapy is an indicator for risk profiles prone to atherogenesis.
First, elevated level of testosterone following replacement therapy is major indicator for increase of peak VO2 in affected men with heart failure explaining improvement of exercise tolerance in these patients [ 7, 8].
